Back to the main directory
EarningsReview / Equity
- Hipay - 2023 recovery confirmed by 2024 results by MidCap Partners
- Kaufman & Broad - Still very solid by MidCap Partners
- CHINA TRADE, CHINA CREDIT, RIO, STRATEGY, LITHIUM by BNP Paribas Exane
- What is excluded from tariffs and what’s not? by BNP Paribas Exane
- 4QFY25 preview: Stable connection by BNP Paribas Exane
- INVEST SECURITIES - TOOSLA : Feuille de route 2027 confortée - ACHAT, OC 2,4€ vs 2,6€ by Invest Securities
- Non material data changes by BNP Paribas Exane
- Zijin Mining (2899 HK/601899 CH) by HSBC
- China Beer Industry by HSBC
- Pharmaceuticals: coverage dropped by BNP Paribas Exane
- Trump hints at auto tariff reprieve by BNP Paribas Exane
- Cruising through feedback by BNP Paribas Exane
- SCA (Buy, TP: SEK160.00) - Resilient earnings in harsh markets by DnB Markets
- Cool Company (Buy, TP: NOK120.00) - Persevering through the storm by DnB Markets
- Alleima (Buy, TP: SEK100.00) - Pricing power and excess cash by DnB Markets
- Kesko (Buy, TP: EUR20.50) - Feeding stability by DnB Markets
- Tele2 (Hold, TP: SEK140.00) - Beneficiary of peak uncertainty by DnB Markets
- CATL (300750 CH) by HSBC
- Tesco (TSCO LN) by HSBC
- Solid in difficult conditions: results first take by BNP Paribas Exane
- The final ascent by BNP Paribas Exane
- Wafer Woes by BNP Paribas Exane
- Tariff impacts likely to be focus of Q1 results by BNP Paribas Exane
- In the Flow by BNP Paribas Exane
- Corem - Hold: Encouraging communication on divestments by Nordea